All published articles of this journal are available on ScienceDirect.
The Protective Role of the Ratio of Arterial Partial Pressure of Oxygen and Fraction of Inspired Oxygen after Re-Supination in the Survival of Patients with Severe COVID-19 Pneumonia
Abstract
Background
The role of the ratio between the arterial partial pressure of oxygen and the inspired fraction of oxygen (PaO2/FiO2 ratio) during the change in position is not fully established.
Methods
This retrospective, single-center cohort study included 98 patients with severe COVID-19 pneumonia.
Objective
This study aimed to evaluate the predictive value of the PaO2/FiO2 ratio for survival in patients with severe COVID-19 pneumonia between changing from supine to prone positions and vice versa. The PaO2/FiO2 ratio was measured preproning (T0), 30 min to 1 hour (T1), and 48 h after prone positioning (T2), and 30 min to 1 h after re-supination (T3).
Results
The PaO2/FiO2 ratio at T2 and T3 was higher in the survivors than in the non-survivors (T2= 251.5 vs. 208.5, p= 0.032; T3= 182 vs. 108.5, p<0.001). The PaO2/FiO2 ratio at T3 was an independent protective factor (Hazard Ratio (HR)= 0.993; 95% Confidence Interval (CI)= 0.989-0.998; p= 0.006) for survival. A threshold of ≤129 for the PaO2/FiO2 ratio at T3 predicted non-survival with a sensitivity and specificity of 67.86 and 80.95, respectively (Area Under the Curve (AUC)= 0.782; 95% CI 0.687-0.859).
Conclusion
The PaO2/FiO2 ratio is a significant protective factor of survival in severe COVID-19 pneumonia within 30 min-1 hour after returning to the supine position (re-supination).
1. INTRODUCTION
The benefits of the prone position in patients with acute respiratory failure have been documented since 1976 [1]. Improved gas exchange with an increased arterial oxygen partial pressure (PaO2) and a decreased arterial partial pressure of carbon dioxide (PaCO2) in Acute Respiratory Distress Syndrome (ARDS) is well described [2]. However, the most important thing regarding the prone position is the decrease in mortality when it is implemented early (< 48 hours); it is especially used once ARDS has been diagnosed, and for at least 16 hours in patients with severe hypoxemia (PaO2/FiO2 <150 mmHg) [3-5]. The pneumonia caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been identified as Coronavirus Disease 2019 (COVID-19). Up to 80% of COVID-19-related intubated patients have died [6, 7]. Therefore, guidelines for the care of critically ill adult patients with COVID-19 have recommended the use of the prone position [8]. The use of protective mechanical ventilation in terms of airway volume and pressure, including the prone position, is another strategy that can reduce the fatal outcome at 28 days (RR 0.74, 95% CI 0.61-0.88) [9]. Thus, the prone position should be accompanied by a low Tidal Volume (VT) [10], limiting plateau Pressure (Pplat) [11], Mechanical Power (MP) [12], Driving Pressure (DP) [13], and favorable Ventilatory Efficiency (VE) [14]. Together, these interventions could reduce the risk of Ventilator-induced Lung Injury (VILI), which is a reflection of inappropriate pressures and volumes, i.e., excessive stress and strain [15].
Invasive Mechanical Ventilation (IMV) in the supine position does not fully benefit lung function; the different gravitational forces between the dependent and nondependent regions cause the pleural Pressure (Ppl) to be more negative in non-dependent areas, which increases transpulmonary Pressure (Ptpl) and causes greater alveolar distension. In dependent areas, where Ppl is less negative, the opposite effect is obtained, and as a result, Ptpl is lower, translating into less alveolar distension [16]. Ventilation in the prone position favors the homogeneous distribution of Ptpl that generates more uniform ventilation, improves the diaphragmatic excursion of the dorsal region, and decreases the “mechanical effect” of the mediastinal structures (mainly the heart), redistributing ventilation. On the other hand, ventilation in the prone position causes redistribution of pulmonary blood flow, improving the ventilation/perfusion (V/Q) ratio [17]. Finally, respiratory mechanics benefit from improved distensibility of the chest wall and lung parenchyma. Together, these changes increase the PaO2/FiO2 ratio and decrease PaCO2 [2, 18]. It has been proposed that a “prolonged” (more than 36 hours) prone position is safe and free of major adverse events in patients with ARDS secondary to SARS-CoV-2; likewise, the improvement could be greater and sustained [19]. However, in many patients, the improvement in the PaO2/FiO2 ratio is not sustained after resupination, which could be associated with patient outcomes. Therefore, our research aimed to determine survival by observing the change in the values of this index from the supine position to the prone position and vice versa.
2. MATERIAL AND METHODS
2.1. Study Population
This was a longitudinal retrospective observational cohort study. The data were collected from October 2, 2023, to November 30, 2023. The data of the patients who met the inclusion criteria and were admitted to the Intensive Care Unit (ICU) of a tertiary hospital were recorded. The data consisted of the medical records of patients who had met the inclusion criteria. The family members of the research participants signed the written informed consent for admission to intensive care and for the use of medical data for research purposes without the publication of their name or social security number that could contribute to their identification. Patients over 18 years of age were included and children were not included.
2.2. Patients
Convenience sampling was performed, and the records of patients admitted to the ICU with a diagnosis of severe COVID-19 pneumonia were included. The inclusion criteria were age ≥18 years, SARS-CoV-2 infection confirmed by Reverse Transcriptase-Polymerase Chain Reaction (RT‒PCR) test, ARDS defined according to the Berlin criteria [20], having received invasive mechanical ventilation, and prone position [21] for at least 48 continuous hours, as part of the treatment. Patients in the prone position for less than 48 continuous hours and patients with incomplete medical records were excluded. The prone position was considered for those patients with a ratio between partial pressure of oxygen and inspired fraction of oxygen (PaO2/FiO2) <150 mmHg, Positive End Expiratory Pressure (PEEP) ≥5 cmH2O, and FiO2 ≥0.6. Ventilatory support was carried out with Puritan Bennett 840 ventilators. This was a non-intervention study so the informed consent present in the medical records was that of admission to the ICU.
2.3. Data Collection
Data of the patients meeting the inclusion criteria were obtained from the electronic medical records. Clinical parameters, including sex, age, comorbidities, and respiratory parameters, were collected on ICU admission.
2.4. Definitions
Prone and supine positioning and monitoring of respiratory parameters. The prolonged prone position was defined as the anatomical position of the human body lying face down and with the head on one side, the neck in a neutral position, and the thoracic extremities extended and placed next to the trunk for more than 48 continuous hours [22]. After orotracheal intubation of patients with severe COVID-19 pneumonia, the PaO2/FiO2 ratio was measured pre-proning (T0), 30 min to 1 hour (T1), and 48 h after prone positioning (T2), and 30 min to 1 h after re-supination (T3). The PaO2/FiO2 ratio was obtained as the ratio between the partial pressure of oxygen (PaO2) and the fraction of inspired oxygen (FiO2). The Driving Pressure of the respiratory system (DP) was calculated as the difference between Plateau Pressure (Pplat) and the levels of Positive End Expiratory Pressure (PEEP). Compliance of the Respiratory System (CRS) was defined as the product between Tidal Volume (VT) and DP. Mechanical Power (MP) was calculated according to Gattinoni´s simplified formula: 0.098 x Respiratory Rate (RR) x VT x (peak Pressure (Ppeak) – (PPLAT - PEEP/2)). Ventilatory Ratio (VR) was determined as (minute ventilation (ml/min) x PaCO2 (mmHg))/(predicted body weight (kg) x 100 x 37.5).
2.5. Statistical Analysis
Data have been reported as numbers (percentage) for categorical variables and mean (Standard Deviation (SD)) or median (interquartile range (IQR)) for continuous variables. The Shapiro‒Wilk test was used to evaluate the normality assumption of continuous variables. Non- normally distributed continuous variables were compared using the Mann‒Whitney U-test, and normally distributed continuous variables were compared with the Student’s t-test. The categorical variables between the groups were compared using the chi-square test or Fisher´s exact test. Friedman´s test was used to compare the PaO2/FiO2 ratio at T0, T1, T2, and T3 within each group, and if statistical significance was detected, multiple comparisons were carried out with Wilcoxon´s signed-rank test for post-hoc comparisons between the related values. The bivariate correlation between the variables under study was assessed using the Spearman correlation coefficient. A univariate Cox regression analysis was performed, and only the variables significantly associated with the non-survival of COVID-19 patients were entered into a multivariate model with a stepwise method. In this regard, the Hazard Ratios (HRs) together with 95% Confidence Intervals (CIs) were estimated. Receiver Operating Characteristic (ROC) curve analysis was applied to evaluate the predictive value of the PaO2/FiO2 ratio, considering the Area Under the Curve (AUC). The Kaplan-Meir survival curve to estimate survival according to the best cutoff point of the PaO2/FiO2 ratio at T3 was constructed. The statistical significance of the differences between the categories of PaO2/FiO2 ratio was calculated using the log-rank test. A p-value <0.05 was considered statistically significant. Statistical analysis was performed using R Studio (version 1.0.153), SPSS 25.0 (SPSS Inc., Chicago, IL, USA), and MedCalc (Software 8.1.1.0; Mariakerke, Belgium).
3. RESULTS
98 patients with a diagnosis of severe COVID-19 pneumonia were included in the statistical analysis; they were classified as survivors and non-survivors (Fig. 1). Demographic and clinical characteristics by subgroup are described in Table 1. The survivor group had a median age of 60.4 years old ±14.75 compared to 66 years old ±11.09 in the non-survivor group; the difference exhibited statistical significance.
Among the variables that were considered of interest for the clinical evolution of patients with severe COVID-19 pneumonia, sex, age, medical comorbidities, Pressure plateau (Pplat), Driving Pressure (ΔP), Compliance of the Respiratory System (CrS), Mechanical Power (MP), and Ventilatory Ratio (VR) stood out (Table 1). In all patients, the following variables were calculated: the PaO2/FiO2 ratio was measured pre-proning (T0), 30 min to 1 hour (T1), and 48 h after prone positioning (T2), and 30 min to 1 h after resupination (T3). The findings have emphasized a PaO2/FIO2 value in the highest T3 in the survivors group compared to non-survivors, i.e., 182mmHg (105.5mmHg) and 108.5mmHg (68mmHg), respectively (p=0.001; Table 1).
The univariate and multivariate analyses of the variables of interest have highlighted age (>55 years old) with HR 1.045 (95% CI 1.016-1.074; p=0.001) to lead to fatal outcomes. Likewise, T3 (after re-supination (after 48 hours in prone position)) has exhibited an HR of 0.993 (95% CI 0.989-0.998; p=0.006; Table 2).
Variable | Total (n= 98) | Survivors (n = 42) | Non-survivors (n = 56) | p-value |
---|---|---|---|---|
Female, n (%) | 34 (34.7) | 13 (31) | 21 (37.5) | 0.50a |
Age (years) | 63.6 ±13.01 | 60.4 ±14.75 | 66 ±11.09 | 0.035b |
BMI (kg m-2) | 32.66 (6.72) | 32.65 (6.67) | 33.67 (7.55) | 0.135c |
Diabetes, n (%) | 45 (45.9) | 13 (31) | 32 (57.1) | 0.01a |
AH, n (%) | 65 (66.3) | 23 (54.8) | 42 (75) | 0.036a |
Smoking, n (%) | 32 (32.7) | 8 (19) | 24 (42.9) | 0.013a |
CKD, n (%) | 7 (7.1) | 1 (2.4) | 6 (10.7) | 0.233d |
Cardiopathy, n (%) | 6 (6.1) | 4 (9.5) | 2 (3.6) | 0.397d |
Lactate (mg/dL) | 1.6 (0.9) | 1.7 (0.85) | 1.6 (0.78) | 0.297b |
PPLAT (cmH2O) | 23.37 ±3.47 | 22.90 ±3.27 | 23.73 ±3.60 | 0.245b |
ΔP (cmH2O) | 14.62 ±3.25 | 14.47 ±3.27 | 14.73 ±3.26 | 0.702b |
CRS (ml/cmH2O) | 32.75 ±9.64 | 35.92 ±9.15 | 30.37 ±9.38 | 0.004b |
MP (J/min) | 18.59 (7.97) | 18.45 (7.31) | 18.81 (8.81) | 0.983c |
VR | 1.84 (0.72) | 1.88 (0.73) | 1.82 (0.70) | 0.994c |
T0 | 76.5 (36.5) | 87 (41.25) | 70.5 (30.75) | 0.008c |
T1 | 171 (84.5) | 180 (66.5) | 160 (85.5) | 0.141c |
T2 | 226.5 (126) | 251.5 (115.25) | 208.5 (136.25) | 0.032c |
T3 | 141 (103.75) | 182 (105.5) | 108.5 (68) | <0.001c |
Definition of abbreviations: BMI= body mass index; AH= arterial hypertension; CKD= chronic kidney disease; PPLAT= plateau pressure; ΔP= driving pressure of respiratory system; CRS= compliance of the respiratory system; MP= mechanical power; VR= ventilatory ratio; T0= value of the PaO2/FiO2 ratio in the supine position after intubation; T1= value of the PaO2/FiO2 ratio during the session 30 min to 1 hour after the patient was placed into prone position; T2= value of the PaO2/FiO2 ratio between 1 h to 8 h after prone positioning; T3= value of the PaO2/FiO2 ratio between 30 min to 1 h after the patient had returned to the supine position.
Variable | Univariable | Multivariable | ||||
---|---|---|---|---|---|---|
HR | (95% CI) | P-value | HR | (95% CI) | P-value | |
Female | 1.4 | 0.815-2.424 | 0.223 | - | - | - |
Age | 1.03 | 1-1.05 | 0.012 | 1.045 | 1.016-1.074 | 0.001 |
BMI | 1.02 | 0.993-1.06 | 0.116 | - | - | - |
Diabetes | 1.37 | 0.8-2.33 | 0.244 | - | - | - |
AH | 1.59 | 0.871-2.918 | 0.131 | - | - | - |
Smoking | 1.38 | 0.817-2.363 | 0.061 | - | - | - |
CKD | 1 | 0.422-2.378 | 0.996 | - | - | - |
Cardiopathy | 0.82 | 0.20-3.39 | 0.794 | - | - | - |
Lactate | 0.91 | 0.6-1.37 | 0.659 | - | - | - |
PPLAT | 1.03 | 0.95-1.11 | 0.389 | - | - | - |
ΔP | 1.03 | 0.95-1.12 | 0.432 | - | - | - |
CRS | 0.98 | 0.95-1.01 | 0.22 | - | - | - |
MP | 0.996 | 0.953-1.041 | 0.873 | - | - | - |
VR | 1.122 | 0.738-1.704 | 0.591 | - | - | - |
T0 | 0.997 | 0.989-1 | 0.514 | - | - | - |
T1 | 0.998 | 0.995-1 | 0.542 | - | - | - |
T2 | 0.997 | 0.993-1 | 0.073 | - | - | - |
T3 | 0.9958 | 0.9917-0.9998 | 0.042 | 0.993 | 0.989-0.998 | 0.006 |
Definition of abbreviations: BMI= body mass index; AH= arterial hypertension; CKD= chronic kidney disease; PPLAT= plateau pressure; ΔP= driving pressure of respiratory system; CRS= compliance of the respiratory system; MP= mechanical power; VR= ventilatory ratio; T0= value of the PaO2/FiO2 ratio in the supine position after intubation; T1= value of the PaO2/FiO2 ratio during the session 30 min to 1 hour after the patient was placed in prone position; T2= value of the PaO2/FiO2 ratio between 1 h to 8 h after prone positioning; T3= value of the PaO2/FiO2 ratio between 30 min to 1 h after the patient had returned to the supine position.
When comparing the PaO2/FiO2 in the groups of survivors and non-survivors, T2 stood out as 251.5mmHg and 208.5mmHg, respectively (p= 0.032), and T3 as 182mmHg and 108.5mmHg, respectively (p <0.001; Fig. 2). The dynamic changes in the PaO2/FiO2 ratio at T0, T1, T2, and T3 within each group were also evaluated in this study. With the Friedman test, it was highlighted that the group of survivors presented high levels of PaO2/FiO2 for time T0, T1, T2, and T3 compared to the group of non-survivors (T0 = 87 (45.25), T1 = 180 (66.5), T2= 251.5 (115.25), T3= 182 (105.5), consecutively (p <0.00001 in all cases)) (Fig. 3). On the other hand, the PaO2/FiO2 ratio was increased at T2 compared to T0, T1, and T3 in the non-survivors )T0= 70.5 (30.75) vs. T1= 160 (85.5) vs. T2= 208.5 (136.25) vs. T3= 108.5 (68), p <0.00001). Through the ROC curve analysis, the ratio was compared at different times (Fig. 4A-D). Additionally, the results of the Area Under the Curve (AUC), best cutoff point, Youden´s index, Sensitivity (S), Specificity (Sp), Positive and Negative Predictive Values (PPV, NPV), and likelihood ratios for the PaO2/FiO2 ratio at T0, T1, T2, and T3 are shown in Table 3.
Variable | AUC | Best Cut-off | Youden’s Index | Sensitivity (%) | Specificity (%) | p-value | NPV | PPV | -LR | +LR |
---|---|---|---|---|---|---|---|---|---|---|
T0 | 0.656 | ≤77 | 0.309 | 64.29 | 66.67 | 0.005 | 0.58 | 0.72 | 0.54 | 1.93 |
T1 | 0.587 | ≤185 | 0.208 | 73.21 | 47.62 | 0.133 | 0.57 | 0.65 | 0.56 | 1.40 |
T2 | 0.627 | ≤142 | 0.232 | 30.36 | 92.86 | 0.024 | 0.50 | 0.85 | 0.75 | 4.25 |
T3 | 0.782 | ≤129 | 0.488 | 67.86 | 80.95 | <0.0001 | 0.65 | 0.82 | 0.40 | 3.56 |
The PaO2/FiO2 ratio at time T3 of <129mmHg presented an AUC of 0.782 with S and Sp of 67.8% and 80.9%, respectively (Table 3). The PaO2/FiO2 ratio at T0 was positively correlated with age (r= 0.266, p= 0.008), whereas the PaO2/FiO2 ratio at T1 (r= 0.126, p= 0.215), T2 (r= 0.135, p= 0.184), and T3 (r= 0.165, p= 0.105) showed no significant correlation with age (Fig. 5A-D). A Kaplan‒Meier survival curve was plotted (Fig. 6) according to the best cutoff point (≤129mmHg) of the PaO2/FiO2 ratio at T3, which demonstrated a lower survival over time (p= 0.015).
4. DISCUSSION
In this study, our goal was to avoid both hypoxemia and hyperoxemia. PaO2 levels between 60-100mmHg [23] and peripheral oxygen saturation (SpO2) between 92% and 96% indicate COVID-19 infection in patients [24]. An SpO2 of < 92% has been reported to indicate an increased risk of mortality (HR 1.62; 95% CI 1.02-2.56) [25] as well as an SpO2 > 96% (RR 1.21; 95% CI 1.03-1.43) [26]. When possible, besides SpO2, the sigmoid shape of the oxygen dissociation curve should be considered. Pulse oximetry between 92% and 96% can represent a PaO2 between 60 and 200 mmHg, which can be an extremely different value with an important connotation regarding the treatment [27].
Variations in PaO2/FiO2 when placing the patient in the prone position or at weaning are important, but the benefit of this position goes beyond a variable. It has been documented that there is a 53% increase in PaO2/FiO2 in patients with moderate to severe ARDS; 12 hours after its start, the prone position improves survival HR 0.11 (95% CI 0.05-0.25, p=<0.001) [28]. In contrast, the decrease in the PaO2/FiO2 value upon returning to the supine position is associated with an increase in the need for tracheostomy and even mortality. In addition, the “sustained improvement” of PaO2/FiO2 when returning to the supine position is independently associated with extubation success (RR 1.563, 95% CI 1.329-1.838, p = <0.001) [29]. Similar to this, our research has demonstrated higher PaO2/FiO2 values at both T2 and T3 in the survivor group. However, only the PaO2/FiO2 ratio at T3 (HR= 0.993; 95% CI 0.989-0.998, p= 0.006) has been an independent predictor of death in COVID-19 patients with ARDS. The survivor group had a higher level of CRS (35.92 ± 9.15 vs. 30.37 ±9.38, p <0.005) than the non-survival group. This variable has been reported to be associated with discharge from the ICU at 28 days, but to not be a predictor of mortality [30].
The elimination of CO2 is as important as the increase in oxygenation. Recruitment of well-perfused but poorly ventilated units decreases shunts and, thus, favors CO2 elimination. The Ventilatory Ratio (VR) is a simple parameter that assesses alveolar ventilation. Its normal value is ~1, without units. The VR is mainly determined by dead-space fraction (VD/VT) and is an independent predictor of mortality. Among patients with ARDS, VR has been found to be higher in non-survivors [31]. Among patients with COVID-19 who required invasive mechanical ventilation, the increase in VR from ICU admission compared to day 3 was associated with mortality (OR 1.4, CI 1.01-1.07, p= 0.030), regardless of PaO2/FiO2 variations (OR 0.99, CI 0.95-1.02, p= 0.47) [32]. Dead space could predict mortality in patients with ARDS [33]; however, in our patient population, there were no differences in VR between the survivors and non-survivors or in PPLAT, DP, and MP between the survivors and non-survivors. Thus, it can be stated that a prolonged prone position (~48 hours) is viable, and at a greater number of hours, the benefits are greater, and there is no increase in the inherent risks of this anatomical position. Even a prolonged prone position could be useful for preserving oxygenation improvement after resupination [34-36].
The limitations of our study are stated as follows: the study was carried out at a single center, it was retrospective, the sample size was small, the mechanical ventilation protocol was not standardized (although the protective ventilation strategy was used), and we did not report adverse events of any kind regarding the prolonged prone position. However, our strength is that we have reported patients to share homogeneous baseline characteristics.
CONCLUSION
The results obtained in this study, although analyzed retrospectively, have suggested the dynamic evolution of lung disease in severe COVID-19 pneumonia, with age being an independent variable for fatal outcomes; however, what was most notable is the evolution of the ratio PaO2/FiO2 at different times in the clinical evolution, that is, the PaO2/FiO2 values measured in T2 could translate the gasometric paremeters’ response to the orotracheal intubation maneuver and prone position, but the T3 time (re-supination) was the most predictive for the final outcome.
AUTHORS’ CONTRIBUTION
J.S.S.D. and K.G.P.M.: Conceptualized the study, administered the project, and wrote the original draft; J.S.S.D., K.G.P.M., and D.E.M.: Designed the methodology; D.E.M. and J.M.R.R.: Conducted the formal analysis; J.S.S.D., J.M.R.R., and O.R.P.N.: Analyzed the data; J.S.D.D., O.R.P.N., and E.M.Z.: Contributed to visualization; J.S.S.D.: Contributed to writing, review, and editing.
LIST OF ABBREVIATIONS
PaO2/FiO2 | = Arterial partial pressure of oxygen and inspired fraction of oxygen |
ARDS | = Acute respiratory distress syndrome |
COVID-19 | = Coronavirus disease 2019 |
SARS-CoV-2 | = Severe acute respiratory syndrome coronavirus 2 |
ETHICS APPROVAL AND CONSENT TO PARTICIPATE
The research protocol was approved (code number R-2021-3001-050) by the Ethics and Research Committee from UMAE H. E. No. 14. Additionally, this study is retrospectively registered on Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS, Federal Commission for the Protection against Sanitary Risks) with the number 17 CI 11020 146.
HUMAN AND ANIMAL RIGHTS
All human research procedures followed were in accordance with the ethical standards of the committee responsible for human experimentation (institutional and national), and with the Helsinki Declaration of 1975, as revised in 2013.
CONSENT FOR PUBLICATION
The informed consent document has been available from the family member responsible for the patient at the time of admission to the intensive care unit, which also pertained to the protection of personal data.
STANDARDS OF REPORTING
The research was conducted based on the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) methodology for observational studies.